Beyond the RCT: Real-World Photobiomodulation Data in APOE4 Carriers
What happens when you stop waiting for the perfect RCT and start tracking real people, in real life, over real time? That's exactly what our next Discussion Round is about. On June 4th, we're joined by Dr. Kevin Tran — founder of The Phoenix Community, a Doctor of Pharmacy, a former BCG and Simon-Kucher advisor, and an APOE4/4 carrier himself. Kevin has built the first science-driven membership platform for APOE4 carriers focused on Alzheimer's prevention, now serving over 4,000 members actively tracking their health data together. He'll be presenting findings from the Phoenix-Neuronic photobiomodulation study: 11 APOE4 carriers running a structured 4-month protocol, with data spanning device usage, sleep, HRV, blood biomarkers, and more. Neuronic's data analyst will be joining live for the formal statistics. This is a candid look at what real-world prevention research actually looks like — what worked, where the methodology fell short, and what comes next. If you're a clinician, researcher, or practitioner serious about brain health and Alzheimer's prevention, this one is not to miss.
